{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T22:51:28Z","timestamp":1787007088756,"version":"build-2736575974"},"reference-count":157,"publisher":"Informa UK Limited","issue":"4","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Therapeutic Patents"],"published-print":{"date-parts":[[2017,4,3]]},"DOI":"10.1080\/13543776.2017.1272571","type":"journal-article","created":{"date-parts":[[2016,12,18]],"date-time":"2016-12-18T22:53:06Z","timestamp":1482101586000},"page":"455-476","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":152,"title":["Recent advances in acetylcholinesterase Inhibitors and Reactivators: an update on the patent literature (2012-2015)"],"prefix":"10.1080","volume":"27","author":[{"given":"Stanton F.","family":"McHardy","sequence":"first","affiliation":[{"name":"Center for Innovative Drug Discovery, Department of Chemistry, University of Texas San Antonio, One UTSA Circle, San Antonio, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua-Yu Leo","family":"Wang","sequence":"additional","affiliation":[{"name":"Center for Innovative Drug Discovery, Department of Chemistry, University of Texas San Antonio, One UTSA Circle, San Antonio, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelby V.","family":"McCowen","sequence":"additional","affiliation":[{"name":"Center for Innovative Drug Discovery, Department of Chemistry, University of Texas San Antonio, One UTSA Circle, San Antonio, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew C.","family":"Valdez","sequence":"additional","affiliation":[{"name":"Center for Innovative Drug Discovery, Department of Chemistry, University of Texas San Antonio, One UTSA Circle, San Antonio, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2017,1,17]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1016\/0301-0082(93)90040-Y"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3495(95)80159-1"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.2174\/1570159X11311030006"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1999.0705"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1016\/0041-0101(94)90416-2"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2007.11.013"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2013.06.021"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1042\/BJ20130013"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2008.05.035"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1021\/cr00081a005"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1039\/b600517a"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1021\/cn300178k"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1021\/jm300871x"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1042\/BJ20111675"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1038\/nrn1035"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1021\/ja0512780"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-3057(96)00431-5"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1126\/science.1132814"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2008.06.005"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.2174\/138161206778792985"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1038\/nrn.2015.1"},{"key":"CIT0022","first-page":"401","volume":"25","author":"Padurariu M","year":"2013","journal-title":"Psychiat Danub"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1016\/S0896-6273(00)80108-7"},{"key":"CIT0024","doi-asserted-by":"crossref","first-page":"111","DOI":"10.31887\/DCNS.2000.2.2\/lschneider","volume":"2","author":"Schneider L S","year":"2000","journal-title":"Dialog in Clin Neurosci"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1159\/000212371"},{"key":"CIT0026","first-page":"1","volume":"10","author":"Mehndiratta MM","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2014-308764"},{"key":"CIT0028","first-page":"1","volume":"3","author":"Rolinski M","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1177\/0891988704267463"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.2174\/13895575113136660108"},{"key":"CIT0031","doi-asserted-by":"publisher","DOI":"10.2174\/1570159X11311030006"},{"key":"CIT0032","first-page":"305","volume-title":"Chemical Warfare Agents: Toxicology and Treatment 2007","author":"Eyer PA"},{"key":"CIT0033","doi-asserted-by":"publisher","DOI":"10.2174\/092986709788612729"},{"key":"CIT0034","doi-asserted-by":"publisher","DOI":"10.1002\/jat.3048"},{"key":"CIT0035","doi-asserted-by":"publisher","DOI":"10.1517\/17425255.2013.736489"},{"key":"CIT0036","doi-asserted-by":"publisher","DOI":"10.1002\/jat.3048"},{"issue":"22","key":"CIT0037","first-page":"853","volume":"2012","author":"de los Rios C","journal-title":"Expert Opin Ther Patents"},{"key":"CIT0038","doi-asserted-by":"publisher","DOI":"10.1517\/13543776.2012.701620"},{"key":"CIT0039","first-page":"1","volume":"2","author":"Lopez-Arrieta JM","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"CIT0040","doi-asserted-by":"publisher","DOI":"10.1177\/106002809402800612"},{"key":"CIT0041","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1994.03510370044030"},{"key":"CIT0042","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2013.02.017"},{"key":"CIT0043","doi-asserted-by":"publisher","DOI":"10.1016\/S0896-6273(00)80108-7"},{"key":"CIT0044","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.18-09-03213.1998"},{"key":"CIT0045","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2008.05.026"},{"key":"CIT0046","doi-asserted-by":"publisher","DOI":"10.1002\/prot.24267"},{"key":"CIT0047","unstructured":"Univ Guangxi Chinese Medicine. 9-amino substituted pyrido acridine derivative, preparation method and uses thereof. CN104327075; 2014."},{"key":"CIT0048","doi-asserted-by":"publisher","DOI":"10.1254\/jjp.89.7"},{"key":"CIT0049","unstructured":"Cheng X. Novel derivatives of donepezil. US2015225343; 2015."},{"key":"CIT0050","unstructured":"INSA. Oxidisable pyridine derivatives, their preparation and use as anti-Alzheimer agents. WO2014114742; 2014."},{"key":"CIT0051","unstructured":"INSA. New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-Alzheimer agents. WO2006103120;2006."},{"key":"CIT0052","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.9.10.2393"},{"key":"CIT0053","doi-asserted-by":"publisher","DOI":"10.1021\/cr040415t"},{"key":"CIT0054","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-5793(99)01637-3"},{"key":"CIT0055","unstructured":"Univ East China Science & Tech., Galantamine analogue and application thereof. CN104860955; 2015."},{"key":"CIT0056","doi-asserted-by":"publisher","DOI":"10.1139\/v86-137"},{"key":"CIT0057","doi-asserted-by":"publisher","DOI":"10.2174\/0929867003375281"},{"key":"CIT0058","doi-asserted-by":"publisher","DOI":"10.1039\/c1sc00455g"},{"key":"CIT0059","unstructured":"Insero Health Inc. Conjugates of huperzine and analogs thereof. US20150191430;2015."},{"key":"CIT0060","doi-asserted-by":"publisher","DOI":"10.1016\/S0099-9598(08)60084-X"},{"key":"CIT0061","doi-asserted-by":"publisher","DOI":"10.1159\/000008243"},{"key":"CIT0062","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200115050-00004"},{"key":"CIT0063","doi-asserted-by":"publisher","DOI":"10.1177\/0091270007312154"},{"key":"CIT0064","unstructured":"Teikoku Pharma USA Inc. Rivastigmine transdermal compositions and methods of using the same. TW201603835; 2016."},{"key":"CIT0065","unstructured":"Noven Pharmaceuticals, Inc. Silicone-containing acrylic polymers for transdermal drug delivery compositions. US20160030362;2016."},{"key":"CIT0066","doi-asserted-by":"publisher","DOI":"10.1021\/jm049782n"},{"key":"CIT0067","doi-asserted-by":"publisher","DOI":"10.1021\/jm100573q"},{"key":"CIT0068","unstructured":"Council of Scientific and Industrial Research. Substituted carbamic acid quinolin-6-yl esters useful as acetylcholinesterase inhibitors. WO2006070394;2006."},{"key":"CIT0069","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2012.09.005"},{"key":"CIT0070","unstructured":"Council of Scientific and Industrial Research. Substituted 1, 2, 3, 4-tetrahydroquinolin-7-yl carbamates as acetylcholinesterase inhibitors for treatment of Alzheimer\u2019s disease. US20130324573;2013."},{"key":"CIT0071","doi-asserted-by":"publisher","DOI":"10.1021\/jm7009364"},{"key":"CIT0072","doi-asserted-by":"publisher","DOI":"10.2174\/092986711797535245"},{"key":"CIT0073","doi-asserted-by":"publisher","DOI":"10.2174\/1570159X14666160119094820"},{"key":"CIT0074","doi-asserted-by":"publisher","DOI":"10.3390\/ph4020382"},{"key":"CIT0075","doi-asserted-by":"publisher","DOI":"10.1021\/jm0503289"},{"key":"CIT0076","doi-asserted-by":"publisher","DOI":"10.1021\/jm050746d"},{"key":"CIT0077","doi-asserted-by":"publisher","DOI":"10.1007\/s12640-009-9121-2"},{"key":"CIT0078","doi-asserted-by":"publisher","DOI":"10.1021\/jm00045a020"},{"key":"CIT0079","unstructured":"Centrum Medyczne. Novel hybrid cholinesterase inhibitors. US20140080860;2014."},{"key":"CIT0080","unstructured":"Univ China Pharma. Tacrine-beta-carboline conjoined multifunction cholinesterase inhibitor. CN104003987;2014."},{"key":"CIT0081","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2014.08.035"},{"key":"CIT0082","first-page":"299","volume":"60","author":"Fleck C","year":"2010","journal-title":"Arzneimittelforschung"},{"key":"CIT0083","unstructured":"Univ Sun Yat Sen. Tacrine-caffeic acid hetero-blends, their preparation method and medicinal compositions. CN102617465;2012."},{"key":"CIT0084","unstructured":"Univ Sun Yat Sen. Tacrine-ferulaic acid hetero-blend, preparation method and pharmaceutical compositions thereof. CN101284812;2008."},{"key":"CIT0085","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2012.08.036"},{"key":"CIT0086","unstructured":"Univ Hefei Technology. Tacrine-phenothiazine isodiad compound and preparation method thereof. CN102936244;2013."},{"key":"CIT0087","doi-asserted-by":"publisher","DOI":"10.1007\/s00044-014-0931-2"},{"key":"CIT0088","doi-asserted-by":"publisher","DOI":"10.1021\/jm049112h"},{"key":"CIT0089","unstructured":"Univ Huazhong Science Tech. Sulfydryl-containing tacrine derivative and preparation method and application thereof. CN102391180;2012."},{"key":"CIT0090","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2013.05.028"},{"key":"CIT0091","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(08)70167-4"},{"key":"CIT0092","doi-asserted-by":"publisher","DOI":"10.1021\/jm100329q"},{"key":"CIT0093","unstructured":"Univ Southeast. Deferasirox-tacrine metal ion chelating agent and pharmaceutical use thereof. CN104817538;2015."},{"key":"CIT0094","doi-asserted-by":"publisher","DOI":"10.1039\/c3sc51902c"},{"key":"CIT0095","doi-asserted-by":"publisher","DOI":"10.1111\/bph.12240"},{"key":"CIT0096","unstructured":"Jiangsu Simcere Pharmaceutical. Hydrogenated acridine derivative and application thereof. CN103524413;2014."},{"key":"CIT0097","unstructured":"Chen R, Feng L, Zhang Z, et al. 1,4-dihydro-naphthyridine derivative and pharmaceutical composition and use thereof. US20140364443;2014."},{"key":"CIT0098","unstructured":"Jiangsu Simcere Pharmaceutical. 5-amino-1,4-dihydro-1,8-naphthyridine derivative and pharmaceutical composition and use thereof. WO2013152704;2013."},{"key":"CIT0099","unstructured":"Jiangsu Simcere Pharmaceutical. Compounds and uses as L-type calcium channel blocker and\/or acetylcholinesterase inhibitor thereof. WO2012065527;2012."},{"key":"CIT0100","doi-asserted-by":"publisher","DOI":"10.1021\/jm801292b"},{"key":"CIT0101","doi-asserted-by":"publisher","DOI":"10.1021\/jm901902w"},{"key":"CIT0102","doi-asserted-by":"publisher","DOI":"10.1021\/jm300106z"},{"key":"CIT0103","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2013.03.005"},{"key":"CIT0104","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2013.03.051"},{"key":"CIT0105","doi-asserted-by":"publisher","DOI":"10.1021\/jm5008648"},{"key":"CIT0106","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2013.09.024"},{"key":"CIT0107","doi-asserted-by":"publisher","DOI":"10.1021\/jm201460y"},{"key":"CIT0108","unstructured":"Zhejiang University. 2-methoxyphenyl-dimethylamino formic ether derivative and preparation method and application thereof. CN103420941;2013."},{"key":"CIT0109","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2008.05.003"},{"key":"CIT0110","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2014.07.009"},{"key":"CIT0111","unstructured":"Universite de Rouen. 7,11-methanocycloocta[B]Quinoline derivative as highly functionalizable acetylcholinesterase inhibitors. US20150197735;2015."},{"key":"CIT0112","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2004.05.006"},{"key":"CIT0113","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-141959"},{"key":"CIT0114","unstructured":"Jiangsu Simovay Pharmaceutical Co. 1,2,4-thiadiazole-3,5-dione derivatives, and pharmaceutical composition and application thereof. CN103992312;2014."},{"key":"CIT0115","unstructured":"Huaihai Inst Technology. Amino sugar thiazole derivative as well as synthetic method and application thereof. CN104292280;2015."},{"key":"CIT0116","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2008.06.005"},{"key":"CIT0117","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2011.09.061"},{"key":"CIT0118","unstructured":"Kunming Inst Botany CN ACAD. Pyrrolidone compounds as well as medical composition and application thereof. CN104800209;2015."},{"key":"CIT0119","unstructured":"ISIS Innovation. Immunogenic composition. WO2009150433;2009."},{"key":"CIT0120","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jcim.5b00449"},{"key":"CIT0121","unstructured":"Univ Guangzhou Chinese Medicine. Application of 2-phenyl-benzo-five membered heterocycle compound and derivative of 2-phenyl-benzo-five-membered heterocycle compound. CN104829569;2015."},{"key":"CIT0122","unstructured":"Hangzhou Zhongmei Huadong Pharmaceutical Co LTD. 2-aminothiazole derivatives and methods of preparing and using the same. US2014004155;2014."},{"key":"CIT0123","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-012-8258-9"},{"key":"CIT0124","doi-asserted-by":"publisher","DOI":"10.1159\/000353689"},{"key":"CIT0125","doi-asserted-by":"publisher","DOI":"10.1038\/302832a0"},{"key":"CIT0126","doi-asserted-by":"publisher","DOI":"10.1038\/bjp.2008.147"},{"key":"CIT0127","unstructured":"Richter Gedeon Nyrt. H<sub>3<\/sub> antagonists containing phenoxypiperidine core structure. US20160009645;2014."},{"key":"CIT0128","doi-asserted-by":"publisher","DOI":"10.1016\/j.fitote.2013.06.010"},{"key":"CIT0129","unstructured":"Univ Lanzhou Tech. Stemona root alkaloid monomer components and applications thereof. CN103387580;2013."},{"key":"CIT0130","unstructured":"Inst Materia Medica Cams. Clavatine A-C and preparation method as well as pharmaceutical composition and application thereof. CN103059043;2013."},{"key":"CIT0131","doi-asserted-by":"publisher","DOI":"10.1021\/ol3009478"},{"key":"CIT0132","doi-asserted-by":"publisher","DOI":"10.1007\/s11426-013-4967-9"},{"key":"CIT0133","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2010.06.130"},{"key":"CIT0134","doi-asserted-by":"publisher","DOI":"10.1186\/1752-153X-6-96"},{"key":"CIT0135","unstructured":"Kunming Inst Botany CN ACAD. Compound 1,10-N-decylene lycorine dibromo salt, pharmaceutical composition and application thereof in medicine. CN102746325;2012."},{"key":"CIT0136","volume-title":"Phytochemical Dictionary: A Handbook of Bioactive Compounds from Plants","author":"Harborne JB","year":"1999","edition":"2"},{"key":"CIT0137","doi-asserted-by":"publisher","DOI":"10.1080\/10286021003610136"},{"key":"CIT0138","unstructured":"Guiyang College Traditional Chinese Medicine. Use of 20alpha-dimethylamino-2alpha-hydroxy-3beta-tiropramide-5alpha-pregnane. CN102813659;2012."},{"key":"CIT0139","unstructured":"Univ Shenyang Chemical Tech. Triterpene compounds with acetylcholinesterase inhibition activity, and preparation method thereof. CN104788525;2015."},{"key":"CIT0140","unstructured":"Univ Guangzhou Chinese Medicine. Coumarone derivative, and preparation method and applications thereof. CN103333163;2013."},{"key":"CIT0141","unstructured":"University of Iowa Research Foundation. Compounds and methods to treat organophosphorus poisoning. US20140323473;2014."},{"key":"CIT0142","volume":"9227937","author":"Mississippi State University","year":"2016","journal-title":"U"},{"key":"CIT0143","unstructured":"Southwest Res Inst. Reactivators of organophosphorous inhibited acetylcholinesterase. US20140350262;2014."},{"key":"CIT0144","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2014.02.049"},{"key":"CIT0145","unstructured":"Southwest Res Inst. Oximes for the treatment of peripheral and central nervous system exposure to acetyl cholinesterase inhibitors. US20150005328;2015."},{"key":"CIT0146","unstructured":"Univ California, Scripps Research Inst. Centrally active and orally bioavailable antidotes for organophosphate exposure and methods for making and using them. US20150361060;2015."},{"key":"CIT0147","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M111.333732"},{"key":"CIT0148","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M111.230656"},{"key":"CIT0149","unstructured":"Human Biomolecular Research Institute. Blood brain barrier-penetrating oximes for cholistenerases reactivation. WO2012083261; 2012."},{"key":"CIT0150","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.21519"},{"key":"CIT0151","unstructured":"Universite de Strasbourg, Fr.; Commissariat a l'Energie Atomique et aux Energies Alternatives; Centre National de la Recherche Scientifique; Universite de Rouen; L'Etat Francais (Ministere de la Defense) Represente par le Directeur de l'Institut de Recherche Biomedicale des Armees. Pyridine derivatives as uncharged reactivators of human acetylcholinesterase and their preparation and use for the treatment of nervous and respiratory failure. WO 2015075082; 2015."},{"key":"CIT0152","unstructured":"The Trustees Of Columbia University In The City Of New York. Activation or reactivation of AChE. WO2014210168; 2014."},{"key":"CIT0153","doi-asserted-by":"publisher","DOI":"10.1002\/cbic.201500348"},{"key":"CIT0154","first-page":"451","volume":"4","author":"T-M Shih","year":"2012","journal-title":"Aip Studies Bio"},{"key":"CIT0155","doi-asserted-by":"publisher","DOI":"10.1002\/anie.201508227"},{"key":"CIT0156","doi-asserted-by":"publisher","DOI":"10.1007\/BF00570145"},{"key":"CIT0157","doi-asserted-by":"crossref","first-page":"18S","DOI":"10.1177\/1091581813490204","volume":"32","author":"Clark APZ","year":"2013","journal-title":"Int J Toxicol"}],"container-title":["Expert Opinion on Therapeutic Patents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13543776.2017.1272571","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,17]],"date-time":"2022-07-17T19:13:58Z","timestamp":1658085238000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13543776.2017.1272571"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,17]]},"references-count":157,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4,3]]}},"alternative-id":["10.1080\/13543776.2017.1272571"],"URL":"https:\/\/doi.org\/10.1080\/13543776.2017.1272571","relation":{},"ISSN":["1354-3776","1744-7674"],"issn-type":[{"value":"1354-3776","type":"print"},{"value":"1744-7674","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,17]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ietp20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ietp20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2016-04-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-12-05","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-01-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}